Copyright
©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 5768-5777
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5768
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5768
Table 1 Data on new therapeutic protocol efficacy and safety in post-liver transplantation period
| Charltonet al[13] | Fornset al[68] | Pellicelliet al[69] | |
| Patients (n) | 40 | 104 | 12 |
| Regimen | SOF + RBV | SOF + RBV + pegIFN | SOF + DCV |
| Patients with cirrhosis | 40% | 50% | 75% |
| End of treatment response | 100% | 87% | 100% |
| Sustained viral response 12 | 70% | 62% | NA |
| Sustained viral response 24 | 70% | NA | NA |
| Serious adverse events | 15% | 33% | 30% |
| Deaths | 0 | 12.5% | 25% |
- Citation: Filipec Kanizaj T, Kunac N. Hepatitis C: New challenges in liver transplantation. World J Gastroenterol 2015; 21(19): 5768-5777
- URL: https://www.wjgnet.com/1007-9327/full/v21/i19/5768.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i19.5768